Colorado Rockies outfielder Kris Bryant has received a platelet-rich plasma (PRP) injection in the hopes of speeding along his recovery from plantar fasciitis in his left foot.
Bryant signed a seven-year, $182 million contract in the offseason with the Colorado Rockies, but has played in just 42 games this season because of back issues, plantar fasciitis, and family time away from the team for the birth of his twins.
So what comes next for Kris Bryant and the Colorado Rockies?
Colorado manager Bud Black said on Wednesday before the series conclusion with the Texas Rangers at Coors Field that Bryant had received the PRP injection and that there would not be any updates for the next week to 10 days.
“Hopefully that plasma will take effect,” Black said.
According to Johns Hopkins, PRP treatment uses a patient’s own blood cells to accelerate healing in a specific area.
The clock is ticking on Bryant’s potential for return in 2022 as the Rockies have just 38 regular-season games remaining, including Wednesday’s tilt with Texas. Colorado leaves Coors Field after Wednesday on a 10-game, 11-day road trip through New York (Mets), Atlanta, and Cincinnati.
Bryant talked about his latest injury and the frustration that goes along with it recently with the media, saying that he first felt the effects of plantar fasciitis during Colorado’s road trip to Arizona at the very start of July. He tried to play through the pain but realized during the road series in Milwaukee (Colorado’s first series after the All-Star break) that he wasn’t going to be able to battle through the issues.
He was placed on the 10-day injured list (his third trip to the IL this season) on August 1 and has been in a walking boot trying to get past the issue.
Bryant was slashing .400/.483/.680 over the last seven games before going on the IL, adding to the frustration for both him and the Rockies of a season that has been disappointing on all sides.